Investors need to pay close attention to About Alkermes (ALKS) stock based on the movements in the options market lately.

Market OverviewThe Addiction Rehab Facilities Market, valued at USD 16.8 billion in 2023, is anticipated to experience substantial growth, reaching about USD 31.3 billion by 2032. This growth ...

Alkermes is positioned for outperformance due to its conservative cash-heavy balance sheet and high-margin business model.

The price-to-earnings ratio for Alkermes plc (NASDAQ:ALKS) is 9.65. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E ...

Alkermes plc (Nasdaq: ALKS) today announced the presentation of research related to its psychiatry franchise ...

Alkermes plc last week announced it had completed the sale of its development and manufacturing facility in Athlone, to Novo ...

Alkermes plc (Nasdaq: ALKS) has completed the previously announced sale of its development and manufacturing facility ...

Alkermes (NASDAQ:ALKS) just reported results for the first quarter of 2024. Alkermes reported earnings per share of 44 cents. This was below the analyst estimate for EPS of 58 cents. The company ...

Alkermes (ALKS) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.59 per share. This compares to earnings of $0.01 per share a year ago. These figures are ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.